Mechanisms of acquired crizotinib resistance in ALK-rearranged lung Cancers.

Katayama, Ryohei

Mechanisms of acquired crizotinib resistance in ALK-rearranged lung Cancers. [electronic resource] - Science translational medicine Feb 2012 - 120ra17 p. digital

Publication Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't

1946-6242

10.1126/scitranslmed.3003316 doi


Anaplastic Lymphoma Kinase
Cell Line, Tumor
Crizotinib
Drug Resistance, Neoplasm--genetics
Humans
Immunoblotting
Immunohistochemistry
In Situ Hybridization, Fluorescence
Lung Neoplasms--drug therapy
Mutation
Polymerase Chain Reaction
Protein Kinase Inhibitors--therapeutic use
Pyrazoles--therapeutic use
Pyridines--therapeutic use
Receptor Protein-Tyrosine Kinases--genetics